Drug Safety Monitor

SAFETY ALERT

The Institute for Safe Medication Practices (ISMP) has recently issued several alerts regarding medication errors resulting from confusion of four different products (Celebrex, Celexa, Cerebyx, and Cerebra). Celebrex, Celexa and Cerebyx are all KUMC formulary products. Please refer to the following table for clarification of the use of these products:

Brand Name

Generic Name

Uses

Celebrex

celecoxib

Relief of the signs and symptoms of osteoarthritis and rheumatoid arthritis.

Celexa

citalopram

Selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of depression.

Cerebyx

fosphenytoin

Control of generalized convulsive status epilepticus and prevention and treatment of seizures occurring during neurosurgery. It can also be substituted, short-term, for oral phenytoin.

Cerebra

huperzine A

Herbal supplement claimed to enhance focus, memory, and concentration.

Suggestions to reduce the likelihood of medication errors includes
                    Include the indication on prescriptions written for these drugs
                    Separate these drugs in all storage areas
                    Closely check the appearance of all new drugs
                    Closely review all labels against the prescribed medication.

Return to Drug Safety Monitor Home Page